Immune and neuroendocrine modulation with thymosins: current status of recent clinical trials in the United States.
Badamchian
M
M
Department of Biochemistry and Molecular Biology, George Washington University Medical Center, Washington D.C. 20037.
Goldstein
A L
AL
Sztein
M B
MB
D000368:Aged; D016207:Cytokines / Q000502:physiology; D004311:Double-Blind Method; D004341:Drug Evaluation; D006509:Hepatitis B / Q000188:drug therapy*; D006801:Humans; D007252:Influenza Vaccines / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000628:therapy*; D008222:Lymphokines / Q000502:physiology; D008954:Models, Biological; D011897:Random Allocation; D006435:Renal Dialysis; D000077596:Thymalfasin; D013947:Thymosin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014481:United States
D016207:Cytokines; D007252:Influenza Vaccines; D008222:Lymphokines; D013947:Thymosin; D000077596:Thymalfasin